Axonal Guillain-Barré syndrome is underestimated in Europe?

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 10, 2010, Pages 1063-

  Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE;

CAMPYLOBACTER JEJUNI; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; EUROPE; GUILLAIN BARRE SYNDROME; HUMAN; MOLECULAR MIMICRY; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NONHUMAN; NOTE; PRIORITY JOURNAL; CLASSIFICATION;

EUROPE; GUILLAIN-BARRE SYNDROME; HUMANS;

EID: 77958117183     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.213421     Document Type: Note

References (6)

1. Hughes RAC, Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653-66.
2. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
3. Ogawara K, Kuwabara S, Mori M, et al. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol. 2000;48:624-31.
4. Unccini A, Manzoli C, Noutturno F, et al. Pitfalls in electrodianosis of Guillain - Barré syndrome subtypes. J Neurol Neurosurg Psychiatry 2010;81:1157-63.
5. Yuki N. Carbohydrate mimicry: a new paradigm of autoimmune diseases. Curr Opin Immunol 2005;17:577-82. (Pubitemid 41506900)
6. Susuki K, Rasband MN, Tohyama K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 2007;27:3956-67. (Pubitemid 46597169)